Delivery Order SPE2DB22D1200-SPE2DB25FN0AA
Award Date
1/23/25
Potential Completion Date
1/24/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $1,300.85 for the supply of the ROTATEQ vaccine. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense. The contract is a firm fixed price delivery order with an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization and leading global...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the ROTATEQ vaccine in 2 milliliter doses. The fixed-price delivery order, valued at $4,034.38, was awarded by the Defense Logistics Agency (DLA) on November 5, 2024, with a completion date of November 6, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.58 firm fixed-price delivery order is for the ROTATEQ vaccine, a vaccine for the prevention of rotavirus gastroenteritis in children. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,289,025 units of the ROTATEQ VACCINE 2ML to the Defense Logistics Agency (DLA). The delivery order is valued at $13,284.52, with a firm fixed price and an ultimate completion date of April 17, 2024. The contract is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of the ROTATEQ vaccine, a 2-milliliter dose of the rotavirus vaccine. The $2,012.76 firm-fixed price delivery order has an ultimate completion date of December 10, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.29 Firm Fixed Price delivery order contract is for the supply of 4,566,659,449 units of the ROTATEQ vaccine, a critical pharmaceutical product used for disease prevention. The contract has an ultimate completion date of December 10, 2024. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $5,837.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of the ROTATEQ Vaccine, a 2ML vaccine product. The contract has an ultimate completion date of December 4, 2024 and a Firm Fixed Price pricing type. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,009.64 Delivery Order is for the supply of the ROTATEQ vaccine, a 2 mL dosage. The contract is a Firm Fixed Price arrangement with a completion date of May 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $15,765.90 contract is for the supply of the ROTATEQ vaccine, a 2 ml dosage form, with a performance period through March 13, 2024. This delivery order is issued under a single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to...
This $2,605.24 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of 4,565,164,820 units of the ROTATEQ vaccine. The order has a completion date of July 17, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through...